September 20, 2021 -- Thermo Fisher Scientific announced that it has launched two new products. The first product is an adeno-associated virus (AAV) production system, while the second is a digital polymerase chain reaction (dPCR) system.
The Gibco AAV-MAX helper-free AAV production system aims to simplify the workflow involved in AAV vector production by delivering high viral titers using Viral Production Cells 2.0, a new, clonally documented, 293F-derived mammalian cell line.
Additionally, the company unveiled the Applied Biosystems QuantStudio Absolute Q digital PCR system, which is designed to provide highly accurate and consistent results within 90 minutes. The system uses microfluidic array technology and simpler workflows, and it was designed to improve the accuracy and consistency of data.
Applied Biosystems QuantStudio Absolute Q digital PCR system, an integrated digital PCR solution, can be used for oncology, cell and gene therapy development, and other research applications. Image courtesy of Thermo Fisher Scientific.
The dPCR technology powering the QuantStudio Absolute Q platform is used by biotech companies and academic institutions for longitudinal monitoring of cancer-driving mutations in liquid biopsy, precise quantification of gene inserts for cell therapy development, and copy-number variation studies for earlier identification of genetic conditions in newborns, the company said.
Copyright © 2021 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
